Vineti announces strategic partnership with Autolus Therapeutics to support delivery of novel T cell therapies

Go back to Vineti announces strategic partnership with Autolus Therapeutics to support delivery of novel T cell therapies
(NASDAQ: AUTL) Delayed: 2.11 --0 (-0%)
Previous Close $2.11    52 Week High
Open $2.11    52 Week Low
Day High $2.11    P/E N/A 
Day Low $2.11    EPS
Volume 618